BIOCRYST PHARMACEUTICALS, INC. Deferred Costs, Current
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Deferred Costs, Current of $9.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2019-05-09
- 2019-03-31: Deferred Costs, Current $9.00K.
- 2018-12-31: Deferred Costs, Current $9.00K.
- 2018-09-30: Deferred Costs, Current $8.00K.
- 2018-06-30: Deferred Costs, Current $12.00K.
| Period end | Deferred Costs, Current |
|---|---|
| 2019-03-31 | $9.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $9.00K 10-Q · filed 2019-05-09 |
| 2018-09-30 | $8.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $12.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $152.00K 10-Q · filed 2018-05-09 |
| 2018-01-01 | $152.00K 10-K · filed 2019-03-14 |
| 2017-12-31 | $210.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $218.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $79.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $82.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $85.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $98.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $89.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $90.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $90.00K 10-K · filed 2017-02-27 |
| 2015-09-30 | $88.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $101.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $76.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $76.00K 10-K · filed 2016-02-26 |
| 2014-09-30 | $76.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $75.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $75.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $75.00K 10-K · filed 2015-03-02 |
| 2013-09-30 | $73.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $73.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $418.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $412.00K 10-K · filed 2014-03-10 |
| 2012-09-30 | $404.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $519.00K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $452.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $2.30M 10-K · filed 2013-03-11 |
| 2011-09-30 | $753.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $751.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $719.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |